glp-1 complications Neurological associated with rapid weight loss and nutritional deficiencies following agonist use: a case report | BMC Neurology GLP-1 receptor agonists and acute

The expression of the receptor MC 2 , which is normally found almost exclusively on the adrenal glands, was found dysregulated in scalp skin samples from alopecia areata, suggesting a deficit for ACTH/MC 2 axis in the pathogenesis of this condition (173)

GLP-1 receptor agonists have emerged as a revolutionary class of medications in the treatment of type 2 diabetes and obesity, offering not just blood sugar control but also significant weight loss benefits

GLP-1 Inhibitors Arent Substance-Specific Currently approved medications for addiction are largely substance-specific

Mechanism: Stimulates pulsatile GH release Increases IGF-1 without desensitizing pituitary Specifically reduces deep abdominal fat Benefits: Reduces visceral fat while maintaining or increasing lean mass Enhances insulin sensitivity and lipid metabolism Supports training capacity in overweight or aging populations Typical Dose: 2 mg subcutaneously once daily Best taken at night before bed IGF-1 LR3: Direct Muscle Growth Stimulation IGF-1 LR3 (Long Arg3) is a modified version of IGF-1 with an extended half-life, allowing for more consistent anabolic signaling